#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14598	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2166	669.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1432	1432	C	851	C,T	797,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14598	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2166	669.5	0	HET	.	.	.	C207T,A	.	207	207	C	455	455	C	861	C,T,A	385,416,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26508	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3630	728.3	0	.	n	.	0	T695C	SNP	695	695	T	1024	1024	C	844	C,T	800,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26508	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3630	728.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2300	2300	C	793	C	736	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26508	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3630	728.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2374	2374	A	783	A	737	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26508	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3630	728.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2926	2926	C	834	C	767	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26508	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3630	728.3	0	HET	.	.	.	A1638G,T	.	1638	1638	A	1967	1967	A	842	A,G,T	430,364,1	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1958	folP	855	855	100.0	folP.l15.c4.ctg.1	1499	129.8	1	SNP	p	R229S	1	.	.	685	687	AGC	962	964	AGC	212;209;210	A;G;C	197;195;196	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5172	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3411	151.2	1	SNP	p	S91F	1	.	.	271	273	TTC	548	550	TTC	176;175;176	T;T;C	167;167;166	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5172	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3411	151.2	1	SNP	p	G95N	0	.	.	283	285	GGC	560	562	GGC	165;164;164	G;G;C	158;155;156	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5172	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3411	151.2	1	SNP	p	D95G	1	.	.	283	285	GGC	560	562	GGC	165;164;164	G;G;C	158;155;156	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1540	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1259	121.3	1	SNP	p	G45D	0	.	.	133	135	GGC	430	432	GGC	192;190;191	G;G;C	175;176;179	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	796	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	927	85.2	0	.	n	.	0	A197.	DEL	197	197	A	520	520	A	201	A	184	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	190.7	1	SNP	p	D86N	0	.	.	256	258	GAC	560	562	GAC	219;218;220	G;A;C	204;193;203	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	190.7	1	SNP	p	R87I	0	.	.	259	261	CGT	563	565	CGT	218;217;218	C;G;T	203;201;195	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	190.7	1	SNP	p	R87W	0	.	.	259	261	CGT	563	565	CGT	218;217;218	C;G;T	203;201;195	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	190.7	1	SNP	p	S87R	1	.	.	259	261	CGT	563	565	CGT	218;217;218	C;G;T	203;201;195	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	190.7	1	SNP	p	S88P	0	.	.	262	264	TCC	566	568	TCC	222;224;227	T;C;C	206;208;212	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4012	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2716	146.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1542	1544	GGC	191;187;187	G;G;C	178;174;171	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2495	147.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1293	1295	GCC	215;213;212	G;C;C	198;195;195	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2495	147.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1296	1298	ATG	216;219;218	A;T;G	196;199;199	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2495	147.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1308	1310	ACC	217;216;216	A;C;C	198;199;200	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2495	147.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1308	1310	ACC	217;216;216	A;C;C	198;199;200	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2495	147.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1809	1811	ACC	195;193;193	A;C;C	176;175;181	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2495	147.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1863	1865	GCG	191;194;197	G;C;G	183;187;187	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2495	147.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1863	1865	GCG	191;194;197	G;C;G	183;187;187	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2495	147.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1986	1988	GGT	145;145;146	G;G;T	135;136;135	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2495	147.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1995	1997	AGC	135;135;135	A;G;C	125;127;125	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2495	147.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2013	2015	CCG	135;136;139	C,G;C,G,T;G	105,6;107,3,1;116	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5564	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3110	178.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1568	1570	CCG	231;233;232	C,T;C;G	199,1;208;199	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2786	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1606	169.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	550	550	C	211	C	196	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2742	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1710	159.5	0	.	p	.	0	I45V	NONSYN	133	135	ATT	453	455	GTT	223;222;224	G,A;T,G;T	207,1;204,1;208	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2742	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1710	159.5	0	.	p	.	0	G48E	NONSYN	142	144	GGA	462	464	GAA	228;231;230	G;A;A	211;214;211	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2742	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1710	159.5	1	SNP	p	G120K	1	.	.	358	360	AAG	678	680	AAG	225;227;223	A,G,C;A,G;G,C	205,1,1;208,1;207,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2742	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1710	159.5	1	SNP	p	N121D	0	.	.	361	363	AAC	681	683	AAC	222;223;222	A,G;A,C;C	208,1;209,1;206	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2742	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1710	159.5	1	SNP	p	A121N	1	.	.	361	363	AAC	681	683	AAC	222;223;222	A,G;A,C;C	208,1;209,1;206	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10238	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4786	213.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1162	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1044	109.4	1	SNP	p	V57M	1	.	.	169	171	ATG	433	435	ATG	251;250;248	A;T;G	237;236;234	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
